Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing geriatric population prone to osteoarthritis
3.2.1.2 Rising demand for minimally invasive treatments
3.2.1.3 New product launches
3.2.1.4 Increasing preference for single injection treatment
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of hyaluronic acid treatment
3.2.2.2 Presence of alternatives for knee osteoarthritis treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.1.1 Sanofi SA
4.1.2 Anika Therapeutics Inc.
4.1.3 Ferring Pharmaceuticals
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Vendor matrix analysis
4.5 Strategy dashboard, 2023
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Single injection
5.3 3 injections
5.4 5 injections
Chapter 6 Market Estimates and Forecast, By Source of Origin, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Avian origin
6.3 Non-avian origin
Chapter 7 Market Estimates and Forecast, By End Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users
Chapter 8 Company Profiles
8.1 Anika Therapeutics, Inc
8.2 Avanos Medical, Inc
8.3 Bioventus Inc.
8.4 Ferring Pharmaceutical
8.5 Fidia Farmaceutici S.p.A (Fidia Pharma USA Inc.)
8.6 Lifecore Biomedical, Inc
8.7 Pacira BioSciences, Inc
8.8 Sanofi SA
8.9 Seikagaku Corporation
8.10 Teva Pharmaceutical Industries Ltd.
